Drug Development
Alexza Pharmaceuticals Updates Staccato(R) Pipeline and Outlines Pipeline Development Strategy
Published in Drug Week, July 30th, 2010
Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) announced that it has selected AZ-007 (Staccato zaleplon) for the treatment of insomnia as the next product candidate to move forward into active development. This decision follows an Alexza technology and portfolio review during the first half of 2010. In addition, Alexza has created Addicere Therapeutics, Inc., a wholly-owned subsidiary, to develop all applications of the Staccato technology for the pharmaceutical uses of nicotine.
"As we started 2010, we deployed the vast majority of our efforts and resources on the pre-commercialization activities for AZ-004. Over the course of the first six months, we received notification...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2010-07-30)
More Articles from Drug Week
- Cochlear Implants
Data from F. Farahmand Ghavi and colleagues advance knowledge in cochlear implants - Seizures
Data on seizures reported by researchers at Medical University of Lublin, Department of Pathophysiology - Anxiety Disorders
Findings from Mayo Clinic in anxiety disorders reported - Post-Operative Pain
Findings from Y. Yukawa and co-authors broaden understanding of post-operative pain - Drug Research
Findings in drug research reported from Imperial College London, Department of Psychological Medicine - Cell Proliferation
Investigators at Sichuan University publish new data on cell proliferation - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
